Clinical trial
Diagnostic Performance of a Novel Lipoarabinomannan Test (FujiLAM) to Detect Tuberculosis in HIV-positive Patients in Kenya
NCT05036694 is registered in ClinicalTrials.gov with Médecins Sans Frontières, Kenya as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diagnostic Performance of a Novel Lipoarabinomannan Test (FujiLAM) to Detect Tuberculosis in HIV-positive Patients in Kenya
- Lead sponsor
- Médecins Sans Frontières, Kenya
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 30, 2021
- Completion date
- December 31, 2022
- Enrollment
- 550 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hiv primary infection